STAT Plus: Catalyst loses lawsuit accusing the FDA of unfairly approving a rival rare disease drug
In a blow to Catalyst Pharmaceuticals (CPRX), a federal judge dismissed its lawsuit accusing the…
Category: legal
STAT Plus: Not by the numbers: Former Aceto controller is charged with insider trading
File this under ‘What was he thinking?’ After spending nearly 17 years as controller at…
.jpg)
STAT Plus: Gilead to pay $97 million for allegedly using a charity to pay kickbacks to Medicare patients
Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it…
STAT Plus: Senators urge bankruptcy judge to prevent Purdue from paying its CEO a $3.5 million bonus
A group of U.S. senators is urging a bankruptcy judge to prevent Purdue Pharma from…
STAT Plus: Teladoc accuses Amwell of infringing on its telehealth patents
Telehealth provider Teladoc last week accused Amwell of infringing on its patents and demanded that…
STAT Plus: Court rules New York can collect taxes from drug makers to address opioid crisis
A U.S. appeals court upheld a controversial New York state law to require drug makers…
STAT Plus: Patent board delivers blow to University of California over its CRISPR invention claims
Making a key ruling in a long-running battle over lucrative patent rights, a government patent…
STAT Plus: Federal judge dismisses lawsuit over patient data sharing by Google and the University of Chicago
A federal judge in Illinois this month dismissed a high-profile lawsuit against Google and the…
STAT Plus: Amarin loses appeal over heart drug patent, dashing its commercial hopes
Amarin failed to convince a federal appeals court to revive key patents covering its heart…
STAT Plus: Coalition urges Justice Department to seek criminal charges against opioid executives
A coalition of advocacy groups and families is asking the Department of Justice to pursue…
STAT Plus: Catalyst takes it fight over a rare disease drug to Canada, suing the country’s regulator
An unusual battle between two small companies over the market for a rare disease drug…
STAT Plus: U.S. authorities expected to file charges against Teva in generic price fixing probe
Federal prosecutors reportedly plan to charge Teva Pharmaceuticals (TEVA) of conspiring with other manufacturers of…
STAT Plus: Cardinal Health is accused of running a ‘rent-a-vet’ scheme to win government contracts
The largest association of independent nuclear pharmacies in the U.S. is accusing Cardinal Health (CAH),…
STAT Plus: Sun Pharma unit to pay $21 million for giving docs false instructions for an acne treatment
A unit of Sun Pharmaceuticals agreed to pay nearly $21 million to settle allegations of…
STAT Plus: Boehringer to pay $379,000 to settle charges of wage discrimination against female employees
Following a review by the Department of Labor, a unit of Boehringer Ingelheim agreed to…
STAT Plus: Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients
Federal authorities alleged that Teva Pharmaceuticals (TEVA) donated hundreds of millions of dollars to a…
STAT Plus: Pharmalittle: Trump touts an unproven salve for Covid-19; states seek big bucks to settle opioid suits
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: Medicaid beneficiaries sue Texas health agency for restricting access to hepatitis C medicines
A group of Medicaid enrollees is accusing a Texas agency of rationing hepatitis C medicines…
STAT Plus: AbbVie pays $24 million to settle lawsuit over using ‘nurse ambassadors’ to boost Humira sales
After two years of wrangling, AbbVie (ABBV) agreed to pay $24 million to settle a…
STAT Plus: Pharmalittle: J&J to supply U.S. with 100 million Covid-19 vaccine doses; Feds seek $18 billion from Purdue in opioid probe
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
Following court ruling, NIH warns drug and device companies to post missing trial data
WASHINGTON — Hundreds of drug companies, medical device manufacturers, and universities owe the public a…
STAT Plus: In a blow to Catalyst, judge recommends tossing its lawsuit against FDA
A federal court judge recommended tossing out a lawsuit filed by Catalyst Pharmaceuticals (CPRX) that…
STAT Plus: Drug maker settles charges of offering ‘bogus’ research grants to boost use of its medicine
In the latest imbroglio involving drug makers and kickbacks, Pacira Biosciences (PCRX) has agreed to…
STAT Plus: Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain
Hello, everyone, and how are you today? We are doing reasonably well, given the circumstances….
.jpg)
STAT Plus: Generic group fails again to block California law that bans pay-to-delay deals
A federal appeals court denied a bid by a pharmaceutical industry trade group to block…
STAT Plus: Pharmalittle: Moderna loses a key patent decision; China says its Covid-19 vaccine will be ready this year
Good morning and happy Friday. Elizabeth Cooney here, thinking of the vacationing Ed Silverman’s weekly…
STAT Plus: Sun Pharma employee says she was fired for complaining that samples were improperly shipped
A former Sun Pharmaceutical sales rep filed a lawsuit arguing she was fired from her…
STAT Plus: Ohio sues Express Scripts for ‘egregiously’ overcharging for medicines
The Ohio Attorney General has filed a lawsuit alleging Express Scripts overcharged a state pension…
STAT Plus: Pharmalittle: FDA fast-tracks two BioNTech and Pfizer vaccines; U.S. hospitals running short of remdesivir
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: Telemedicine is more convenient during Covid-19. It’s also a magnet for fraud and data theft
The increased convenience of telemedicine visits during the Covid-19 pandemic is spurring calls among patients…
Opinion: Covid-19 should spark a reexamination of trade secrets’ stranglehold on information
As the world struggles to confront the Covid-19 pandemic, how to handle access to trade…
STAT Plus: Pharmalittle: Gilead to boost remdesivir supplies in Europe; drug makers announcing $1 billion antibiotic innovation fund
Good morning, everyone, and welcome to another busy day. You made it this far this…
STAT Plus: AbbVie may face fewer wrinkles after judge suggests a 10-year ban on a Botox rival
In a boost for AbbVie (ABBV), a U.S. International Trade Commission judge this week made…
STAT Plus: Alexion to pay $21 million for failing to record bribes paid to doctors in other countries
Alexion Pharmaceuticals (ALXN) agreed to pay more than $21 million for maintaining a false set…
Opinion: A powerful law gives HHS the right to take control of remdesivir manufacturing and distribution
A rare bright spot followed the emergence of Covid-19 and its spread across the globe:…
STAT Plus: Novartis pays $678 million to settle a long-running case over alleged kickbacks to doctors
After seven years of sparring, Novartis (NVS) has agreed to pay $678 million to settle…
STAT Plus: Indivior CEO pleads guilty in connection with a scheme to promote Suboxone
The chief executive of Indivior pleaded guilty to misbranding Suboxone Film, a medicine used to…
Opinion: Regeneron wasn’t making ‘kickbacks.’ It was helping people pay egregious Medicare copays
Last Wednesday, the Department of Justice filed suit against Regeneron for paying ” tens of…
STAT Plus: Pfizer sues Trump administration over anti-kickback rules, saying they prevent it from helping lower seniors’ drug costs
WASHINGTON — Pharmaceutical giant Pfizer is suing the Trump administration over two long-standing Medicare rules…
STAT Plus: Pharmalittle: Sanofi to cut hundreds of jobs; former BARDA chief claims Azar is sabotaging his new job
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: Novartis to pay $345 million to U.S. authorities for bribing doctors in different countries
Novartis (NVS) agreed to pay more than $345 million to resolve criminal charges brought by…
STAT Plus: Pharmalittle: WHO sets goals for distributing Covid-19 treatments; new warnings urged on diabetes drugs
Hello, everyone, and how are you today? A bright shiny sun and cool breezes are…
STAT Plus: After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows
Alarmed that colleagues were bribing Chinese doctors and giving kickbacks to hospital workers to boost…
STAT Plus: Pharmalittle: Europe nears a deal for J&J Covid-19 vaccine; Biogen loses a big patent case
And so, another working week will soon draw to a close. Not a moment too…
STAT Plus: California attorney general says FTC failed to follow ‘best practices’ in approving AbbVie-Allergan deal
Arguing that the Federal Trade Commission did not follow “best practices” in approving AbbVie’s recent…
STAT Plus: Pharmalittle: White House says Covid-19 vaccine will be free to the ‘vulnerable’; vaccine makers hunt for glass vials
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: Smart pill maker Proteus files for bankruptcy, reveals it has held acquisition talks with Otsuka
Smart pill maker Proteus Digital Health on Monday filed for Chapter 11 bankruptcy, the latest…
STAT Plus: Pharmalittle: Cheap steroid reduced deaths in severe Covid-19 patients; what the FDA decision on hydroxychloroquine means
Rise and shine, everyone, another very busy day awaits. Even so, there is nothing like…
STAT Plus: A YouTube ‘hit job’ about a Catalyst Pharma rival is posted amid its battle with the FDA
In a move that resembles a scare tactic, a newly posted YouTube video shows a…
STAT Plus: Pharmalittle: Pfizer CEO says Covid-19 vaccine price won’t be huge; Lilly antibody therapy may be ready by fall
Hello, everyone, and how are you today? Cloudy skies are hovering this morning over the…